ClinicalTrials.gg
RecruitingNCT07894380PIOMIUpdated Oct 26, 2026

Nutritional Maturity in Preterm Newborns (Premature Infant Oral Motor Intervention, PIOMI)

An interventional study of The PIOMI initiative in maternal interaction and Control in Preterm and Preterm Infant Development, sponsored by Ataturk University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 28 Weeks to 32 Weeks, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by Ataturk University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Feb 2026; still recruiting 8 months later.
Updated Oct 26, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
28 Weeks to 32 Weeks
Sex
All
01

Study summary

Premature Infant Oral Motor Intervention (PIOMI) has been found to improve short-term clinical outcomes in preterm infants and contribute to their feeding skills. In preterm infants, PIOMI can improve weight and facilitate early oral feeding. Furthermore, PIOMI can shorten the length of hospital stay and the separation time between the infant and caregiver in preterm infants. The primary aim of this project is to evaluate the effect of PIOMI in mother-infant interaction (applied with the infant in the mother's arms and accompanied by the mother's voice) on feeding readiness, suckling success, mothers' breastfeeding attitudes and infants' feeding maturity in preterm newborns. The secondary objective is to investigate whether PIOMI applied in mother-infant interaction affects mothers' positive and negative emotional states.

02

Conditions studied

  • Preterm
  • Preterm Infant Development

Browse trials for

03

In context

Premature Birth

2,610 studies on the registry are indexed under Premature Birth; 507 are open to participants now.

This study's planned enrollment of 66 is below the median of 84 across 1,722 interventional studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

Ataturk University is the lead sponsor of 456 studies on the registry; 124 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
28 Weeks to 32 Weeks
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • - Infants who are breastfed,
  • have no congenital anomalies or neurological problems,
  • have not undergone surgery,
  • are in stable general condition and are fed enterally,
  • have no respiratory, cardiovascular or gastrointestinal problems that would prevent or complicate oral feeding,
  • and whose parents are willing to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Infants requiring resuscitation,
  • with deteriorating general condition,
  • with additional diagnoses such as sepsis, NEC, etc.,
  • with excessive skin sensitivity, and
  • whose parents wish to be separated from work.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
66 participants (estimated)

Study arms

  • Active comparator
    PIOMI Group

    The PIOMI application will be administered to the control group.

    Other: Control

  • Experimental
    PIOMI initiative focuses on mother-infant interaction

    The PIOMI intervention will be administered to the experimental group during maternal interaction.

    Other: The PIOMI initiative in maternal interaction

Interventions

  • OtherThe PIOMI initiative in maternal interaction

    PIOMI will be administered to preterm infants at YYBÜ alongside feeding procedures. This therapy will be administered once daily for seven consecutive days by the same practitioner, with maternal interaction.

  • OtherControl

    PIOMI application

06

What researchers measure

Primary outcomes

  1. Total Swallow Count

    The Neonatal Oral Feeding Monitor is a non-invasive medical device designed to assess feeding maturity. NeoSAFE takes measurements using two sensors. These sensors are placed under the infant's chin in the hyoid region and on the right abdominal area below the diaphragm to monitor the infant's respiration and swallowing movements during oral feeding. To ensure adequate monitoring, the procedure is carried out for at least two minutes while the data stream from the monitor is observed. Data collected via the sensors are categorized to evaluate the infant's feeding maturity. Description: Total number of detected swallows during feeding.

    Time frame: 1-7 day

  2. Respiration Rate (bpm)

    Description: The amount of infant breath moments recorded per minute during the feeding session. It is expressed in breaths per minute (bpm) and reflects the respiratory function and oxygenation of the infant.

    Time frame: 1-7 day

  3. Inspirium After Swallow Count

    Description: Number of detected inspirium after swallowing events in a feeding session. This parameter is analyzed in two groups: inspiriums that overlap with swallow events and inspiriums that do not overlap with swallows but the interval in between is too short which may lead to aspiration. The total number of Inspirium After Swallow 's is obtained by summing these two groups.

    Time frame: 1-7 day

  4. Overlapped Inspirium After Swallow Events: Overlapped Inspirium After Swallow Percentage & Average Overlapped Inspirium After Swallow Duration

    Description: Overlapped Inspirium After Swallow events represent the number of inspirium states that overlap with swallows. The overlapped Inspirium After Swallow percentage expresses the average percentage of the ratio of the overlap time to total swallow time, whereas the average overlapped Inspirium After Swallow duration represents the average duration of the overlapping inspirium with swallows. These parameters can be better understood with numerical examples, as in the following sections.

    Time frame: 1-7 day

  5. Maximum Rhythmic Swallow

    Description: The maximum number of swallows that the infant can perform in a rhythmic cycle without a resting interval. This parameter represents the number of swallows in the longest rhythmic cycle that the infant demonstrates. It indicates how well the infant can swallow without requiring rest intervals. A higher number suggests that the infant can swallow more smoothly and effectively, while a lower number indicates the need for more rest intervals between swallows.

    Time frame: 1-7 day

  6. Minimum Rhythmic Swallow

    Description: The minimum number of swallows that the infant can perform in a rhythmic cycle without any rest interval. This parameter reflects the infant's swallowing consistency and stability. A higher value indicates the infant can maintain a regular swallowing pattern, while a lower value implies more variability in their swallowing rhythm.

    Time frame: 1-7 day

  7. Average Time Between Rhythmic Swallows

    Description: The average time of the intervals between consecutive rhythmic swallow groups. This parameter shows the infant's resting behavior. A longer interval indicates that the infant takes more extended breaks between the rhythmic swallow events, while a shorter interval suggests the infant swallows more rapidly and smoothly.

    Time frame: 1-7 day

  8. Resting Interval Count

    Description: Total number of rest intervals when rhythmic swallowing is not observed.

    Time frame: 1-7 day

Secondary outcomes

  1. Preterm Infant Oral Feeding Readiness

    Preterm Infant Oral Feeding Readiness Assessment Scale (T-POFRAS): T-POFRAS is an observational scale developed by Fujinaga et al. It consists of 18 items across five categories (corrected gestational age, behavioral organization, oral posture, oral reflexes, and non-nutritive sucking) and assesses oral feeding readiness in preterm infants. The scale is scored from 0 to 2 per item, with a maximum total score of 36. The cutoff score for transitioning a preterm infant to oral feeding was established as 30 (Fujinaga et al., 2013). In the Turkish adaptation of the scale-validated for reliability and validity by Çamur and Çetinkaya-the cutoff score was determined to be 29 (Çamur \& Çetinkaya, 2021). The assessment of the preterm infant using T-POFRAS is conducted as follows: prior to the scheduled feeding time, the researcher first places the infant-who is inside the incubator-in a lateral decubitus position. The infant is awakened through gentle tactile stimulation or by being called by na

    Time frame: 1-7 day

07

Study locations

1 of 1 sites recruiting
  • Ataturk University Faculty of Nursing
    Erzurum, Aziziye, Turkey (Türkiye)
    Recruiting
08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07894380
Lead sponsor
Ataturk University
Responsible party
Türkan Kadiroğlu (Associate Professor, Ataturk University) — Principal investigator
First posted
Oct 26, 2026
Start date
Feb 1, 2026
Primary completion
Sep 1, 2026
Completion
Nov 30, 2026 (estimated)
Last update
Oct 26, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion